Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
Main Authors: | Heba Morobeid, Carmen Pizarro, Leonie Biener, Gudrun Ulrich-Merzenich, Daniel Kütting, Georg Nickenig, Dirk Skowasch |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-08-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/3/00190-2021.full |
Similar Items
-
Lower extremity and carotid artery disease in COPD
by: Carmen Pizarro, et al.
Published: (2016-10-01) -
Successful Smoking Cessation in COPD: Association with Comorbidities and Mortality
by: H. Kupiainen, et al.
Published: (2012-01-01) -
Comorbidity profile of patients with concurrent diagnoses of asthma and COPD in Germany
by: Manas K. Akmatov, et al.
Published: (2020-10-01) -
Asthma is associated with atherosclerotic artery changes.
by: Izabela Tuleta, et al.
Published: (2017-01-01) -
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
by: Donato Lacedonia, et al.
Published: (2021-09-01)